Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro)

T. R. Vrabec, R. C. Sergott, E. A. Jaeger, P. J. Savino, Thomas Bosley

Research output: Contribution to journalArticle

Abstract

Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

Original languageEnglish (US)
Pages (from-to)707-710
Number of pages4
JournalOphthalmology
Volume97
Issue number6
StatePublished - 1990
Externally publishedYes

Fingerprint

Scotoma
Ciprofloxacin
Optic Nerve
Anti-Bacterial Agents

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Vrabec, T. R., Sergott, R. C., Jaeger, E. A., Savino, P. J., & Bosley, T. (1990). Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro). Ophthalmology, 97(6), 707-710.

Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro). / Vrabec, T. R.; Sergott, R. C.; Jaeger, E. A.; Savino, P. J.; Bosley, Thomas.

In: Ophthalmology, Vol. 97, No. 6, 1990, p. 707-710.

Research output: Contribution to journalArticle

Vrabec, TR, Sergott, RC, Jaeger, EA, Savino, PJ & Bosley, T 1990, 'Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro)', Ophthalmology, vol. 97, no. 6, pp. 707-710.
Vrabec, T. R. ; Sergott, R. C. ; Jaeger, E. A. ; Savino, P. J. ; Bosley, Thomas. / Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro). In: Ophthalmology. 1990 ; Vol. 97, No. 6. pp. 707-710.
@article{4aee0c155cc84ddb8526e9e41b803ae7,
title = "Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro)",
abstract = "Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.",
author = "Vrabec, {T. R.} and Sergott, {R. C.} and Jaeger, {E. A.} and Savino, {P. J.} and Thomas Bosley",
year = "1990",
language = "English (US)",
volume = "97",
pages = "707--710",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Reversible visual loss in a patient receiving high-dose ciprofloxacin hydrochloride (cipro)

AU - Vrabec, T. R.

AU - Sergott, R. C.

AU - Jaeger, E. A.

AU - Savino, P. J.

AU - Bosley, Thomas

PY - 1990

Y1 - 1990

N2 - Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

AB - Bilateral acute visual loss characterized by cecocentral scotomas and acquired dyschromatopsia developed in a patient receiving large oral doses of ciprofloxacin hydrochloride (Cipro). The visual defects improved after cessation of this antibiotic. To our knowledge, this association has not been described previously. The use of this medication in high doses must be accompanied by careful monitoring of optic nerve function.

UR - http://www.scopus.com/inward/record.url?scp=0025372416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025372416&partnerID=8YFLogxK

M3 - Article

C2 - 2374675

AN - SCOPUS:0025372416

VL - 97

SP - 707

EP - 710

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 6

ER -